GAM
SRNE

Gotham Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Gotham Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,928
Closed -$222K – 1123
2020
Q3 		$222K Sell
19,928
-12,764
-39% -$117K 0.01% 915
2020
Q2 		$205K Buy
+32,692
New +$125K 0.01% 961
2018
Q3 		– Sell
-130,783
Closed -$942K – 1046
2018
Q2 		$942K Sell
130,783
-34,664
-21% -$236K 0.01% 598
2018
Q1 		$852K Buy
165,447
+122,575
+286% +$872K 0.01% 634
2017
Q4 		$163K Buy
+42,872
New +$112K ﹤0.01% 896

Other funds holding SRNE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return